Refractory Hypercalcemia of malignancy
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB06643 | Denosumab | A RANK ligand (RANKL) inhibitor used for the management of osteoporosis in patients at high risk for bone fractures. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB06643 | Denosumab | Tumor necrosis factor ligand superfamily member 11 | target |
| Drug | Drug Name | Phase | Status | Count |
|---|